J. Jouzeau

发表

Articular Diffusion of Meloxicam After a Single Oral Dose

E. Vignon, D. Loeuille, P. Gillet, 2000, Clinical pharmacokinetics.

Effect of peroxisome proliferator activated receptor (PPAR)gamma agonists on prostaglandins cascade in joint cells.

P. Poleni, S. Sébillaud, P. Netter, 2006, Biorheology.

Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)γ agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1β-stimulated rat chondrocytes: evidence for PPARγ-independent inhibition by 15-deoxy-Δ12,14prostaglandin J2

M. Galteau, S. Sébillaud, P. Netter, 2005, Arthritis research & therapy.

[Pharmacology and classification of cyclooxygenase inhibitors].

P. Netter, J. Jouzeau, A. Bénani, 2004, Gastroenterologie clinique et biologique.

The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide.

J. Pelletier, J. Martel-Pelletier, F. Moldovan, 2002, Arthritis and rheumatism.

Calcium Input Potentiates the Transforming Growth Factor (TGF)-β1-dependent Signaling to Promote the Export of Inorganic Pyrophosphate by Articular Chondrocyte*

P. Reboul, S. Sébillaud, P. Netter, 2011, The Journal of Biological Chemistry.

Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis.

J. Pelletier, J. Martel-Pelletier, P. Netter, 2002, The Journal of rheumatology.

Oxidative stress-induced expression of HSP70 contributes to the inhibitory effect of 15d-PGJ2 on inducible prostaglandin pathway in chondrocytes.

P. Reboul, S. Hupont, P. Netter, 2014, Free radical biology & medicine.

In vitro drug release from HYC 141, a corticosteroid ester of high molecular weight hyaluronan

F. Lapicque, P. Gillet, M. O'regan, 1995 .

Evidence for species differences in the regulation of MMPs by all-trans retinoic acid in cytokine-stimulated chondrocytes.

S. Sébillaud, P. Netter, J. Jouzeau, 2008, Biorheology.

Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue

M. Busslinger, G. Eberl, T. Aychek, 2020, Mucosal Immunology.

Adipose-tissue derived signals control bone remodelling

B. Desvergne, N. Bonnet, D. Pierroz, 2020, bioRxiv.

Effects of human recombinant IL-1β on established experimental arthritis in rats

G. Charriere, P. Gillet, A. Bousseau, 1992, InflammoPharmacology.

Lack of Adipocytes Alters Hematopoiesis in Lipodystrophic Mice

B. Desvergne, N. Bonnet, Carine Winkler, 2018, Front. Immunol..

Identification of two populations of osteoarthritic osteoblasts according to the 1,25[OH]₂ vitamin D₃ potency to stimulate osteocalcin.

P. Reboul, D. Lajeunesse, D. Mainard, 2015, Bio-medical materials and engineering.

Hypoxia and vitamin D differently contribute to leptin and dickkopf-related protein 2 production in human osteoarthritic subchondral bone osteoblasts

P. Reboul, D. Lajeunesse, P. Netter, 2014, Arthritis Research & Therapy.

Modulatory effect of rhein on IL-1alpha-induced responses in human chondrocytes: a comparative study between antibody microarrays and specific ELISAs.

P. Netter, P. Netter, J. Jouzeau, 2008, Biorheology.

Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?

P. Gillet, A. Pinzano, P. Netter, 2012, Arthritis Research & Therapy.

Agonists of peroxisome proliferators-activated receptors (PPAR) α, β/δ or γ reduce transforming growth factor (TGF)-β-induced proteoglycans' production in chondrocytes

P. Poleni, S. Sébillaud, P. Netter, 2007 .

A novel set of hepatic mRNAs preferentially expressed during an acute inflammation in rat represents mostly intracellular proteins.

J. Risler, G. Fey, F. Smih, 1999, Genomics.

Association between adiponectin and cartilage degradation in human osteoarthritis.

A. Abot, D. Mainard, J. Jouzeau, 2014, Osteoarthritis and cartilage.

Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.

S. Boyault, M. Francois, S. Sébillaud, 2005, Arthritis and rheumatism.

Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models

L. Peyrin-Biroulet, S. Danese, N. Ndiaye, 2022, International journal of molecular sciences.

Experimental articular toxicity of aluminum compounds in vivo.

M. Kessler, A. Gaucher, D. Burnel, 1994, The Journal of rheumatology.

The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway.

D. Chappard, G. Weryha, P. Netter, 2013, Arthritis and rheumatism.

Galectin-3: A key player in arthritis.

P. Reboul, J. Jouzeau, H. Ea, 2017, Joint, bone, spine : revue du rhumatisme.

Management of patients with inflammatory bowel disease and spondyloarthritis

D. Loeuille, L. Peyrin-Biroulet, S. Danese, 2017, Expert review of clinical pharmacology.

Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.

J. Jouzeau, D. Moulin, M. Koufany, 2014, Bio-medical materials and engineering.

Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors.

J. Pelletier, J. Martel-Pelletier, S. Laufer, 2002, The Journal of rheumatology.

Association between rheumatoid arthritis and systemic mastocytosis: a case report and literature review

D. Loeuille, I. Latar, P. Netter, 2016, Clinical Rheumatology.

Elucidation of the mechanism of inhibition of cyclooxygenases by acyl-coenzyme A and acylglucuronic conjugates of ketoprofen.

F. Lapicque, N. Levoin, F. Chrétien, 2004, Biochemical pharmacology.

Lack of protective effect of CCR3 blockade during experimental colitis may be related to CCR3 expression by colonic Tregs

L. Peyrin-Biroulet, P. Netter, J. Jouzeau, 2021, Clinical and translational medicine.

Fibroblast Growth Factor 23 drives MMP13 expression in human osteoarthritic chondrocytes in a Klotho-independent manner.

P. Reboul, P. Netter, P. Netter, 2016, Osteoarthritis and cartilage.

The Inorganic Pyrophosphate Transporter ANK Preserves the Differentiated Phenotype of Articular Chondrocyte*

S. Sébillaud, P. Netter, J. Jouzeau, 2010, The Journal of Biological Chemistry.

Cytocompatibility of Ti-6Al-4V and Ti-5Al-2.5Fe alloys according to three surface treatments, using human fibroblasts and osteoblasts.

K. Rie, M. Hage-ali, T. Stucky, 1996, Biomaterials.

Emerging role of IκBζ in inflammation: Emphasis on psoriasis

Sylvain Maenner, P. Reboul, F. Bourgaud, 2022, Clinical and translational medicine.

All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation

S. Sébillaud, P. Netter, J. Jouzeau, 2008, Arthritis research & therapy.

Paradoxical gastrointestinal effects of interleukin-17 blockers

D. Loeuille, L. Peyrin-Biroulet, P. Netter, 2020, Annals of the Rheumatic Diseases.

Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity.

P. Reboul, D. Lajeunesse, J. Jouzeau, 2015, Bone.

Hyaluronidase degradation of hyaluronic acid from different sources: influence of the hydrolysis conditions on the production and the relative proportions of tetra- and hexasaccharide produced.

F. Lapicque, P. Netter, J. Jouzeau, 1993, The International journal of biochemistry.

Plasma surface treatment and PACVD on Ti alloys for surgical implants

R. A. Silva, K. Rie, T. Stucky, 1995 .

Inorganic pyrophosphate generation by transforming growth factor-beta-1 is mainly dependent on ANK induction by Ras/Raf-1/extracellular signal-regulated kinase pathways in chondrocytes

N. Venkatesan, S. Sébillaud, P. Netter, 2007, Arthritis research & therapy.

Multiplex detection of 14 fentanyl analogues and U-47700 in biological samples: Application to a panel of French hospitalized patients.

J. Jouzeau, N. Gambier, V. Gibaja, 2020, Forensic science international.

Gastroenterological safety of IL-17 inhibitors: a systematic literature review

L. Peyrin-Biroulet, P. Miossec, P. Netter, 2021, Expert opinion on drug safety.

Evaluation of the effect of three surface treatments on the biocompatibility of 316L stainless steel using human differentiated cells.

P. Netter, P. Netter, K. Bordji, 1996, Biomaterials.

[Inducible cyclooxygenase. New relationships between non-steroidal anti-inflammatory agents and inhibition of synthesis of prostaglandins].

P. Gillet, T. Lecompte, P. Netter, 1995, Presse medicale.

Cyclo-Oxygenase Isoenzymes

P. Netter, J. Jouzeau, B. Terlain, 1997, Drugs.

Pro- and anti-inflammatory properties of human recombinant IL-1 beta during experimental arthritis in rats: 2. Period-dependent effect.

G. Charriere, P. Gillet, P. Netter, 1993, Life sciences.

Inorganic phosphate (Pi) modulates the expression of key regulatory proteins of the inorganic pyrophosphate (PPi) metabolism in TGF-β1-stimulated chondrocytes.

S. Sébillaud, P. Netter, J. Jouzeau, 2010, Bio-medical materials and engineering.

Secreted Frizzled‐related proteins (sFRPs) in osteo‐articular diseases: much more than simple antagonists of Wnt signaling?

J. Jouzeau, F. Cailotto, Marion Claudel, 2019, The FEBS journal.

TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice

P. Lepage, L. Peyrin-Biroulet, S. Danese, 2018, Journal of Crohn's & colitis.

Online SPE UPLC-MS/MS method for the simultaneous determination of 33 psychoactive drugs from swab-collected human oral fluid samples

J. Jouzeau, N. Gambier, V. Gibaja, 2022, Analytical and Bioanalytical Chemistry.

Uncoupling of oxidative phosphorylation and Smac/DIABLO release are not sufficient to account for induction of apoptosis by sulindac sulfide in human colorectal cancer cells.

J. Merlin, P. Netter, J. Jouzeau, 2005, International journal of oncology.

[Familial articular chondrocalcinosis: study of an Alsatian family].

D. Loeuille, P. Gillet, A. Gaucher, 2001, Bulletin de l'Academie nationale de medecine.

Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences

J. Marchesi, L. Peyrin-Biroulet, S. Danese, 2019, United European gastroenterology journal.

IL‐17 Inhibitors and Inflammatory Bowel Diseases: A Postmarketing Study in Vigibase

L. Peyrin-Biroulet, P. Netter, F. D'Amico, 2021, Clinical pharmacology and therapeutics.

Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis

S. Sébillaud, G. Weryha, P. Netter, 2008, Arthritis research & therapy.

Osteoarthritis: rationale for a new paradigm shift involving transforming growth factor-β1

P. Reboul, D. Lajeunesse, J. Jouzeau, 2013 .

[Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases - the pro and con of agonists].

S. Sébillaud, P. Netter, J. Jouzeau, 2008, Journal de la Societe de biologie.

Rosiglitazone induces interleukin‐1 receptor antagonist in interleukin‐1β–stimulated rat synovial fibroblasts via a peroxisome proliferator–activated receptor β/δ–dependent mechanism

S. Boyault, M. Francois, S. Sébillaud, 2005 .

Lack of Adiponectin Drives Hyperosteoclastogenesis in Lipoatrophic Mice

B. Desvergne, N. Bonnet, D. Pierroz, 2021, Frontiers in Cell and Developmental Biology.

Elevated circulating levels of hyaluronan in long-term hemodialysis patients with dialysis-associated arthropathy: what does it mean?

M. Kessler, A. Gaucher, P. Netter, 1993, Nephron.

Assay of circulating hyaluronic acid in the rat: study of diurnal variation and effect of anesthesia.

P. Gillet, P. Netter, P. Gegout, 1991, Life sciences.

Tofacitinib treatment alters mucosal immunity and gut microbiota during experimental arthritis

H. Sokol, G. Eberl, A. Lavelle, 2020, Clinical and translational medicine.

Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice

H. Sokol, L. Peyrin-Biroulet, P. Netter, 2017, PloS one.

Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

P Netter, P. Netter, J. Jouzeau, 1997, Drugs.

CRDSAT Generated by pCARGHO: A New Efficient Lectin-Based Affinity Tag Method for Safe, Simple, and Low-Cost Protein Purification.

F. Talfournier, S. Boschi-Muller, P. Reboul, 2018, Biotechnology journal.

Death of an Alcohol-Dependent Patient following Intentional Drug Intoxication: Implication of Baclofen?

F. Saint‐Marcoux, J. Jouzeau, N. Gambier, 2014, European Addiction Research.

Anti-Inflammatory Activity of Bryophytes Extracts in LPS-Stimulated RAW264.7 Murine Macrophages

S. Rahuel-Clermont, S. Boschi-Muller, P. Reboul, 2022, Molecules.

Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use.

D. Loeuille, H. Blain, F. Lapicque, 2002, British journal of clinical pharmacology.

Identification of circulating biomarkers of Crohn's disease and spondyloarthritis using Fourier transform infrared spectroscopy

D. Loeuille, O. Bouché, F. Slimano, 2022, Journal of Biophotonics.

Nitric oxide (NO) and cartilage metabolism: NO effects are modulated by superoxide in response to IL-1.

P. Netter, J. Jouzeau, C. Boileau, 2002, Biorheology.

Interest of animal models in the preclinical screening of anti-osteoarthritic drugs.

P. Gillet, P. Netter, J. Jouzeau, 2000, Joint, bone, spine : revue du rhumatisme.

Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1beta in rats.

P. Netter, P. Netter, J. Jouzeau, 1999, Arthritis and rheumatism.

Modulation of IL-1 effects on cartilage by NO synthase inhibitors: pharmacological studies in rats.

P. Netter, J. Jouzeau, B. Terlain, 1999, Osteoarthritis and cartilage.

Modulation of IL‐1‐induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities

P. Netter, J. Jouzeau, B. Terlain, 1998, British journal of pharmacology.

Comment on moving toward targeting the right phenotype with the right platelet-rich plasma formulation for knee osteoarthritis

L. Frenzel, O. Hermine, J. Jouzeau, 2020, Therapeutic advances in musculoskeletal disease.

The infrapatellar fat pad induces inflammatory and degradative effects in articular cells but not through leptin or adiponectin.

P. Reboul, D. Mainard, J. Jouzeau, 2017, Clinical and experimental rheumatology.

Pro- and anti-inflammatory properties of human recombinant IL-1 beta during experimental arthritis in rats: 1. Dependence on dose and severity threshold.

P. Gillet, P. Netter, P. Gegout, 1992, Life sciences.

Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes.

P. Poleni, S. Sébillaud, P. Netter, 2007, Osteoarthritis and cartilage.

Role of nicotinic acid and nicotinamide in nicorandil‐induced ulcerations: from hypothesis to demonstration

A. Barbaud, J. Schmutz, P. Tréchot, 2015, International wound journal.

Separation and quantification by ion-association capillary zone electrophoresis of unsaturated disaccharide units of chondroitin sulfates and oligosaccharides derived from hyaluronan.

F. Lapicque, P. Netter, K. Bordji, 1998, Analytical chemistry.

MicroRNA-29b Contributes to Collagens Imbalance in Human Osteoarthritic and Dedifferentiated Articular Chondrocytes

I. Behm-Ansmant, C. Branlant, J. Jouzeau, 2017, BioMed research international.

Effects of sulphasalazine in experimental arthritis

P. Gillet, J. Floquet, P. Netter, 1993, InflammoPharmacology.

[Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].

H. Blain, C. Jeandel, P. Netter, 2000, La Revue de medecine interne.

Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis

P. Emery, L. Peyrin-Biroulet, W. Sandborn, 2017, Alimentary pharmacology & therapeutics.

[Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases - the pro and con of agonists].

S. Sébillaud, P. Netter, J. Jouzeau, 2008, Journal de la Societe de biologie.

Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism.

P. Netter, J. Jouzeau, B. Terlain, 2001, Biochemical pharmacology.

Influence of muramyl dipeptide on established experimental arthritis in rats.

G. Charriere, L. Chauvelot‐Moachon, B. Bannwarth, 1991, Agents and actions. Supplements.

Overexpression and induction of heat shock protein (Hsp) 70 protects in vitro and in vivo from mono-iodoacetate (MIA)-induced chondrocytes death

C. Contag, C. Fathman, A. Nakajima, 2001, Arthritis Research.

Identification of TGFβ signatures in six murine models mimicking different osteoarthritis clinical phenotypes.

F. Berenbaum, C. Jorgensen, D. Noël, 2020, Osteoarthritis and cartilage.

Galectin-3: A key player in arthritis.

P. Reboul, J. Jouzeau, H. Ea, 2017, Joint, bone, spine : revue du rhumatisme.

Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis.

A. Gepstein, E. Livne, P. Netter, 2004, Osteoarthritis and cartilage.

Interleukin-1 beta differentially represses drug-metabolizing enzymes in arthritic female rats.

P. Gillet, R. Herber, L. Ferrari, 1993, The Journal of pharmacology and experimental therapeutics.

Contrasting effects of peroxisome-proliferator-activated receptor (PPAR) (cid:13) agonists on membrane-associated prostaglandin E 2 synthase-1 in IL-1 (cid:12) -stimulated rat chondrocytes: evidence for PPAR (cid:13) -independent inhibition by 15-deoxy- ∆ 12,14 prostaglandin J 2

M. Galteau, S. Sébillaud, J. Jouzeau, 2020 .